Biological markers for teen depression
Peer-Reviewed Publication
Latest funded news by National Institute on Drug Abuse (NIDA)
Updates every hour. Last Updated: 31-Aug-2025 02:11 ET (31-Aug-2025 06:11 GMT/UTC)
Using a novel lab method they developed, McGill University researchers have identified nine molecules in the blood that were elevated in teens diagnosed with depression. These molecules also predicted how symptoms might progress over time.
The findings of the clinical study could pave the way for earlier detection, before symptoms worsen and become hard to treat.
A new study published in the Journal of Addiction Medicine found that CUD diagnoses rose substantially across all age, race/ethnicity, and comorbidity subgroups nationwide from 2000 to 2022. These diagnoses were consistently higher among people living with HIV, compared to people living without HIV, and people over 65 experienced the greatest relative increase.
Fatal drug overdoses among youth aged 15 to 24 in the United States involving synthetic opioids alone—not mixed with other substances—soared by 168 percent over the five-year time period of 2018 to 2022, a new study shows. Publishing online May 20 in the journal Pediatrics, the work also found that youth overdose rates and drug combinations varied significantly across age, sex and race/ethnicity.
A small cluster of cells deep within our brains, called the locus coeruleus, affects how awake and attentive we are, how we respond to stress, how we cope with anxiety and fear, and how we create memories and learn.This blue spot is also involved in a range of neurological and neuropsychiatric conditions such as anxiety and depression, post-traumatic stress disorder and Alzheimer’s diseases. A new study in mice shows that a small group of cells next to the locus coeruleus, called peri-LC neurons, appear to play a key role in regulating and fine-tuning its information-processing.The findings help explain how we respond appropriately to different challenges, Besides advancing understanding of how our brains regulate arousal, attention and our reactions to distress, the findings open the possibility of new ways to treat neurological and neuropsychiatric disorders, including opioid drug withdrawal symptoms.
A team from MUSC Hollings Cancer Center has just published a paper in JAMA Network Open describing oral nicotine pouch usage – one of the first papers to look at how common this product is.
A new study finds that 11% of American adults reported illicit opioid use within the past 12 months and 7.5% reported use of illicitly produced fentanyl during the same period, rates that are more than 20 times higher than estimates from a large federal study that annually asks Americans about their use of illicit drugs.
In a groundbreaking Genomic Press interview, Dr. Michael Wheeler of Harvard Medical School reveals how psychedelics like psilocybin can reverse stress-induced fear behaviors by modulating neuroimmune pathways. His recent Nature publication demonstrates that psychedelics reduce immune cell accumulation in brain meninges while simultaneously reducing fear behaviors, opening new therapeutic possibilities.